Optimi Health Corp.
Key Metrics
Market Snapshot
About
Optimi Health Corp. (OPTH) is a pharmaceutical and nutraceutical drug manufacturing company based in Princeton, Canada. Incorporated in 2020, it manufactures controlled substances and related wellness products within Canada. The company is known for producing finished MDMA and psilocybin drug products and supplying them to authorized parties.
A central part of the business is the manufacture of controlled substances for medical and research use. Optimi Health Corp. supplies finished MDMA and psilocybin drug products directly to authorized clinics, pharmacies, clinical trials, and partners. It produces MDMA, natural psilocybin, psilocin, and other psychedelic substances, and it also makes functional mushrooms derived from botanical sources for health and wellness markets. This range lets the company serve both regulated medical channels and broader wellness demand.
The company is involved across several steps of production and supply. Its activities include farming, processing, and distributing raw mushroom biomass, producing mushroom extracts, manufacturing drug products, and making mushroom supplements. By handling the chain from cultivation through finished products, the company controls more of how its materials are grown and prepared.
For its consumer oriented products, Optimi Health Corp. uses more than one route to market. It sells through the Amazon marketplace and through distributors and brokers, as well as online. This mix of channels lets it reach wellness customers while it continues to supply controlled substance products through authorized medical and research routes. The combination of regulated drug manufacturing and a functional mushroom and supplement line defines how OPTH operates, with its results tied to demand from clinics, trials, and partners on one side and from health and wellness buyers on the other.